Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

BACKGROUND: In a previous trial of antiretroviral therapy (ART) involving pregnant women with human immunodeficiency virus (HIV) infection, those randomly assigned to receive tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF–FTC–LPV/r) had infants at greater risk for very premature birt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:N Engl J Med
Hlavní autoři: Rough, Kathryn, Seage, George R., Williams, Paige L., Hernandez-Diaz, Sonia, Huo, Yanling, Chadwick, Ellen G., Currier, Judith S., Hoffman, Risa M., Barr, Emily, Shapiro, David E., Patel, Kunjal
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984044/
https://ncbi.nlm.nih.gov/pubmed/29694825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1701666
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky